Image: Fitbit
The heart-monitoring electrocardiogram (EKG) app on Fitbit’s new Sense smartwatch has been cleared by the US Food and Drug Administration (FDA). The feature can track heart rhythms and look for signs of atrial fibrillation, the most common type of irregular heartbeat.
“Our new ECG app is designed for those users who want to assess themselves in the moment and review the reading later with their doctor,” said Eric Friedman, co-founder and chief technology officer at Fitbit, in a statement.
Atrial fibrillation puts people at increased risk for stroke and other heart conditions. Wearable devices can monitor people continuously throughout the day and may be able to flag a problem a traditional heart monitor (which only measures heart rate…